New hope for advanced cancer: first human trial of TGW101 begins
Disease control
Recruiting now
This early-stage study tests a new drug called TGW101 in about 50 adults with advanced solid tumors that have worsened after standard treatments. The main goal is to check safety and find the best dose. Researchers will also look at how the drug moves through the body and whether…
Phase: PHASE1 • Sponsor: Tagworks Pharmaceuticals BV • Aim: Disease control
Last updated May 17, 2026 05:32 UTC